CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc. is a declared insider of CTT Pharmaceutical Holdings, Inc., with filings sourced from SEC (Form 4). The record holds 64 filings, for trades running from 18 February 2022 to 6 October 2026.

Every open-market trade on record is a purchase: 61 purchases worth €50k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants. 2026 to date brings 13 purchases and no sales.

In size, the median ticket on the buying side is €181. Measured against the company's value, the median purchase equals 0.010% of market capitalisation, across 12 purchases where it is known. Across 58 purchases, this insider has always bought alone, with no colleague buying within 30 days. Ninety days after publication, 17 purchases show a median change of +45.8%, with the price up in 65% of them. These figures describe past trades and do not predict future prices.

The latest filing, published on 6 October 2026, reports an open-market purchase of €181 in CTT Pharmaceutical Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.